Patent details

Basic Information

Publication number:

EP2266603

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101704088

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Tumour vaccines

French Title of Invention:

Vaccins contre le cancer

German Title of Invention:

Impfstoffe gegen Krebs

SPC Number:

Dates

Filing date:

16/10/2001

Grant date:

12/09/2012

EP Publication Date:

12/09/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/12/2010

EP B1 Publication Date:

12/09/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/10/2017

Expiration date:

16/10/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/10/2001

 

 

Name:

GlaxoSmithKline Biologicals S.A.

Address:

rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Agent

Name:

KIRKPATRICK SA / NV

From:

19/10/2012

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

Inventor

1

Name:

Stephenne Jean

Address:

Belgium (BE)

2

Name:

Garcon Nathalie

Address:

Belgium (BE)

3

Name:

Gerard Catherine Marie Ghislaine

Address:

Belgium (BE)

Priority

1

Priority Number:

0025574

Priority Date:

18/10/2000

Priority Country:

United Kingdom (GB)

2

Priority Number:

0025573

Priority Date:

18/10/2000

Priority Country:

United Kingdom (GB)

3

Priority Number:

690921

Priority Date:

18/10/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/39;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

20/10/2016

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages